Explore our insights

The COVID-19 crisis has caused significant impact on how businesses are being run. As a result, businesses need to consider supply chain implications to ensure minimal impact on operations led by curtailed manufacturing and weaker demand.

Cyber attack: Maze ransomware

In light of the COVID-19 crisis, most organisations have invoked their business continuity plans (BCPs) across the globe. However, adopting work from home comes with its own set of challenges.

Amidst the COVID-19 crisis, globally mobile individual taxpayers, who may have business connections or income accruals in different jurisdictions, are required to critically examine the impact of this unprecedented health emergency on multi-jurisdiction tax, immigration and other related matters.

The COVID-19 crisis has left the global stock markets in turmoil and many industries staring at an uncertain future.

In light of the ongoing COVID-19 crisis, multinationals are readjusting their supply chains and business models to meet the ever-changing demands of the new ‘now’.

Due to the ongoing COVID-19 crisis, businesses are expected to face considerable liquidity challenges due to sharp reduction in economic activity, amidst concerns of weaker demand for at least the next few quarters.

With major cities across the globe enforcing lockdowns to manage COVID-19 crisis, work from home or remote working has become the new normal.

In light of the ongoing COVID-19 crisis, the depressed business environment is expected to last a few quarters.

In light of the 21-day lockdown announced due to the Coronavirus disease (COVID-19) pandemic, the Department of Promotion of Industry and Internal Trade (DPIIT) has issued guidelines for the State authorities not to obstruct operations/call for closure of food processing units.

In light of the ongoing COVID-19 crisis, the government has recently announced a slew of tax and regulatory relief measures to provide a compliance breather to businesses.

The ongoing Coronavirus (COVID-19) disease pandemic has severely impacted the Indian economy. India Inc. is facing major challenges with the financial year closing and taxpayers therefore need to be more vigilant to minimise any potential impact.

The Coronavirus (COVID-19) disease pandemic has led to massive changes in how organisations operate.

As the coronavirus disease (COVID-19) pandemic disrupts global value chains, the Indian pharmaceutical industry is staring at multiple challenges.

This publication highlights some of the key financial reporting implications that businesses need to consider in preparation of their financial statements during COVID-19 crisis.

The Indian tax and regulatory space is changing at an unprecedented rate. We are witnessing policy announcements, legislative changes, judicial precedents and clarifications almost daily.